Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208

1.

The Portrait of an Adult Liver Transplant Recipient in the United States From 1987 to 2013.

Stepanova M, Wai H, Saab S, Mishra A, Venkatesan C, Younossi ZM.

JAMA Intern Med. 2014 Jun 30. doi: 10.1001/jamainternmed.2014.2903. [Epub ahead of print] No abstract available.

PMID:
24978860
[PubMed - as supplied by publisher]
2.

Editorial: probiotics in NASH - more studies are needed.

Ong JP, Younossi ZM.

Aliment Pharmacol Ther. 2014 Jul;40(2):211-2. doi: 10.1111/apt.12812. No abstract available.

PMID:
24946062
[PubMed - in process]
3.

Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature.

Wong RJ, Kanwal F, Younossi ZM, Ahmed A.

Dig Dis Sci. 2014 Jul;59(7):1586-93. doi: 10.1007/s10620-014-3222-3. Epub 2014 Jun 4.

PMID:
24894512
[PubMed - in process]
4.

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study.

Younossi ZM, Zheng L, Stepanova M, Venkatesan C, Mishra A.

BMJ Open. 2014 May 16;4(5):e004318. doi: 10.1136/bmjopen-2013-004318.

PMID:
24838722
[PubMed]
Free PMC Article
5.

Reply to: "Cost-effectiveness of upcoming treatments for hepatitis C: We need to get the models right"

Younossi ZM, Henry L, Singer M.

J Hepatol. 2014 May 10. pii: S0168-8278(14)00315-8. doi: 10.1016/j.jhep.2014.05.006. [Epub ahead of print] No abstract available.

PMID:
24824281
[PubMed - as supplied by publisher]
Free Article
6.

Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States.

Younossi ZM, Otgonsuren M, Henry L, Arsalla Z, Stepnaova M, Mishra A, Venkatesan C, Hunt S.

J Viral Hepat. 2014 May 12. doi: 10.1111/jvh.12262. [Epub ahead of print]

PMID:
24813350
[PubMed - as supplied by publisher]
7.

Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease.

Mehta R, Birerdinc A, Wang L, Younoszai Z, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM.

BMC Gastroenterol. 2014 Apr 9;14:72. doi: 10.1186/1471-230X-14-72.

PMID:
24716593
[PubMed - in process]
Free PMC Article
8.

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study.

Younossi ZM, Stepanova M, Zeuzem S, Dusheiko G, Esteban R, Hezode C, Reesink HW, Weiland O, Nader F, Hunt SL.

J Hepatol. 2014 Apr 5. pii: S0168-8278(14)00220-7. doi: 10.1016/j.jhep.2014.04.003. [Epub ahead of print]

PMID:
24713186
[PubMed - as supplied by publisher]
9.

Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens.

Younossi ZM, Stepanova M, Nader F, Jacobson IM, Gane E, Nelson D, Lawitz E, Hunt SL.

Hepatology. 2014 Jun;59(6):2161-9. doi: 10.1002/hep.27161. Epub 2014 Apr 30.

PMID:
24710669
[PubMed - in process]
10.

Trends in Outpatient Resource Utilizations and Outcomes for Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease.

Younossi ZM, Zheng L, Stepanova M, Henry L, Venkatesan C, Mishra A.

J Clin Gastroenterol. 2014 Mar 14. [Epub ahead of print]

PMID:
24637730
[PubMed - as supplied by publisher]
11.

The impact of hepatitis C burden: an evidence-based approach.

Younossi ZM, Kanwal F, Saab S, Brown KA, El-Serag HB, Kim WR, Ahmed A, Kugelmas M, Gordon SC.

Aliment Pharmacol Ther. 2014 Mar;39(5):518-31. doi: 10.1111/apt.12625. Epub 2014 Jan 26.

PMID:
24461160
[PubMed - in process]
12.

Multiple factors predict physical performance in people with chronic liver disease.

Loria A, Doyle K, Weinstein AA, Winter P, Escheik C, Price J, Wang L, Birerdinc A, Baranova A, Gerber L, Younossi ZM.

Am J Phys Med Rehabil. 2014 Jun;93(6):470-6. doi: 10.1097/PHM.0000000000000050.

PMID:
24398583
[PubMed - in process]
13.

Statin use is not associated with liver related mortality.

Younoszai Z, Li Z, Stepanova M, Erario M, Cable R, Younossi ZM.

Ann Hepatol. 2013 Jan-2014 Feb;13(1):84-90.

PMID:
24378270
[PubMed - in process]
14.

Predictors of chronic liver disease in individuals with human immunodeficiency virus infection.

Rafiq N, Stepanova M, Lam B, Nader F, Srishord M, Younossi ZM.

Ann Hepatol. 2013 Jan-2014 Feb;13(1):60-4.

PMID:
24378267
[PubMed - in process]
15.

Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C).

Younossi ZM, Stepanova M, Henry L, Gane E, Jacobson IM, Lawitz E, Nelson D, Nader F, Hunt S.

J Hepatol. 2014 Apr;60(4):741-7. doi: 10.1016/j.jhep.2013.12.006. Epub 2013 Dec 11.

PMID:
24333184
[PubMed - in process]
16.

Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C.

Younossi ZM, Stepanova M, Henry L, Gane E, Jacobson IM, Lawitz E, Nelson D, Gerber L, Nader F, Hunt S.

Clin Gastroenterol Hepatol. 2013 Dec 6. pii: S1542-3565(13)01838-7. doi: 10.1016/j.cgh.2013.11.032. [Epub ahead of print]

PMID:
24316172
[PubMed - as supplied by publisher]
17.

A new comorbidity model for predicting mortality in patients with cirrhosis: does it work?

Younossi ZM, Henry L, Stepanova M.

Gastroenterology. 2014 Jan;146(1):19-24. doi: 10.1053/j.gastro.2013.11.026. Epub 2013 Nov 25. No abstract available.

PMID:
24287302
[PubMed - indexed for MEDLINE]
18.

Obesity and liver disease.

Younossi ZM.

Clin Liver Dis. 2014 Feb;18(1):xiii-xiv. doi: 10.1016/j.cld.2013.09.020. Epub 2013 Oct 25. No abstract available.

PMID:
24274879
[PubMed - in process]
19.

Host genetic variants in obesity-related nonalcoholic fatty liver disease.

Mehta R, Birerdinc A, Younossi ZM.

Clin Liver Dis. 2014 Feb;18(1):249-67. doi: 10.1016/j.cld.2013.09.017. Epub 2013 Oct 24.

PMID:
24274878
[PubMed - in process]
20.

Adipose tissue as an endocrine organ.

McGown C, Birerdinc A, Younossi ZM.

Clin Liver Dis. 2014 Feb;18(1):41-58. doi: 10.1016/j.cld.2013.09.012.

PMID:
24274864
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk